title: Underutilization of influenza vaccine in Jerusalem.
abstract: BACKGROUND
  Influenza is an annual winter disease which causes considerable morbidity in the general population and may be lethal in defined high-risk groups. A killed vaccine, recommended for the high-risk groups as well as for several occupational categories, is moderately protective against the disease, but vaccine sales suggest that use is low.
  
  
  RESULTS
  In a hospital-based convenience survey of 295 persons belonging to groups for whom influenza vaccine is recommended, 78 (26.4%) reported having received the vaccine in 1989, and 74 (25.1%) in 1990. All vaccine recipients belonged to the 244 subjects eligible because of advanced age and/or chronic illness, giving vaccination rates in this group of 32.0% in 1989 and 30.3% in 1990. None of the 51 hospital doctors and nurses interviewed had received vaccine. Among the 244 eligible because of age or illness, vaccine receipt in 1990 was related to older age and number of risk factors, but even in subjects with three separate indications for receipt of vaccine, the vaccination rate was only 48%. Among persons advised by anyone to have influenza vaccine, 62.7% received vaccine in at least one of the two years, compared to a rate of 16.4% among subjects never advised to be vaccinated. Vaccine recommendation by a medical professional increased the vaccination rate to 69.3%.
  
  
  CONCLUSIONS
  Influenza vaccine uptake in vaccine eligibles in Jerusalem is low, about 30% in the sick and elderly and considerably lower in medical personnel. Since influenza vaccination can save lives, it would be worthwhile to convince the medical profession to enthusiastically recommend this vaccine to high risk individuals and to explore novel ways of increasing uptake in the high-high risk groups such as persons in hospital or those residing in institutions.
authors.affiliation: Department of Epidemiology, Ministry of Health, Jerusalem, Israel.
authors.forename: P E
authors.initials: PE
authors.lastname: Slater
authors.forename: B
authors.initials: B
authors.lastname: Weidberg-Shmerler
authors.forename: A
authors.initials: A
authors.lastname: Morag
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006282:Health Personnel; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000517:prevention & control*; D007557:Israel; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care
chemical_list: D007252:Influenza Vaccines